Efficacy of biorhythmic transdermal combined hormone treatment in relieving climacteric symptoms: A pilot study

International Journal of General Medicine

Volumn 4, Issue , 2011, Pages 159-163

  Formby, B ^a   Schmidt, F ^a  

^a Rasmus Institute for Medical Research   (United States)

Author keywords

17 estradiol; Circadian rhythms; Estrogen homeostasis; Menopause; Transdermal

Indexed keywords

ESTRADIOL; PROGESTERONE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BIOLOGICAL RHYTHM; CONTROLLED STUDY; CREAM; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG SALIVA LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; PILOT STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84897366921     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S16139     Document Type: Article

References (18)

1. Palacios S. Advances in hormone replacement therapy: making menopause manageable. BMC Women's Health. 2008;8:22-25.
2. Holtorf K. The bioidentical hormone debate. Postgrad Med. 2009; 121(1):4-9.
3. Celec P, Ostatníková D, Skokňová M, et al. Salivary sex hormones during menstrual cycle. Endocr J. 2009;56:521-523.
4. Kupperman HS, Wetchler BB. Contemporary therapy of the menopausal syndrome. JAMA. 1959;171:1627-1637.
5. Albrecht U, Eichele G. The mammalian circadian clock. Curr Opin Genet Dev. 2003;13:271-277.
6. Reppert M, Weaver DR. Molecular analysis of mammalian circadian rhythms. Ann Rev Physiol. 2001;63:647-676.
7. Kruijver EP, Swaab DF. Sex hormone receptors are present in the human supra-chiasmatic nucleus. Neuroendocrinology. 2002;75:296-305.
8. Fu L, Pelicano H, Liu J, et al. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002;111:41-50.
9. Schibler U, Sasssone-Corsi P. A web of circadian pacemakers. Cell. 2002;111:919-922.
10. He P-J, Hirata M, Yamauchi N, et al. Up-regulation of Per1 expression by estradiol and progesterone in the rat uterus. J Endocrinol. 2007;194: 511-519.
11. Xiang S, Coffelt SB, Mao L, et al. Period-2: a tumor suppressor gene in breast cancer. J Cir Rhythms. 2008;6:4-10.
12. Gery S, Virk RK, Chumakov K, et al. The clock gene Per2 links the circadion system to the estrogen receptor. Oncogene. 2007;26: 7916-7920.
13. Gery S, Koeffler H. The role of circadian regulation in cancer. Cold Habor Symp Quantiv Biol. 2007;72:459-464.
14. Chen S-T, Choo K-B, Hou M-F, et al. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancer. Carcinogenesis. 2005;26:1241-1246.
15. McDonnell D, Norris J. Connections and regulation of the human estrogen receptor. Science. 2002;296:1642.
16. Fatehi M, Fatehi-Hassanabad Z. Effects of 17beta-estradiol on neuronal cell excitability and neurotransmission in the suprechiasmatic nucleus of rat. Neuropsychopharmacology. 2008;33:1354-1364.
17. Buster JE. Transdermal menopausal hormone therapy: delivery through the skin changes the rules. Expert Opin Pharmacother. 2010;11:1489-1499.
18. Mahmud K. Natural hormone therapy for menopause. Gynecol Endocrinol. 2010;26:81-85.